Annual Total Expenses:
$1.43B+$286.70M(+25.09%)Summary
- As of today, UTHR annual total expenses is $1.43 billion, with the most recent change of +$286.70 million (+25.09%) on December 31, 2024.
- During the last 3 years, UTHR annual total expenses has risen by +$299.70 million (+26.53%).
- UTHR annual total expenses is now -12.66% below its all-time high of $1.64 billion, reached on December 31, 2019.
Performance
UTHR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Expenses:
$460.80M-$28.30M(-5.79%)Summary
- As of today, UTHR quarterly total expenses is $460.80 million, with the most recent change of -$28.30 million (-5.79%) on September 30, 2025.
- Over the past year, UTHR quarterly total expenses has increased by +$21.00 million (+4.77%).
- UTHR quarterly total expenses is now -46.24% below its all-time high of $857.20 million, reached on March 31, 2019.
Performance
UTHR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
UTHR Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +25.1% | +4.8% |
| 3Y3 Years | +26.5% | +66.5% |
| 5Y5 Years | -12.7% | +120.6% |
UTHR Total Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +49.4% | -5.8% | +73.2% |
| 5Y | 5-Year | -12.7% | +60.6% | -5.8% | +120.6% |
| All-Time | All-Time | -12.7% | >+9999.0% | -46.2% | +689.2% |
UTHR Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $460.80M(-5.8%) |
| Jun 2025 | - | $489.10M(+3.6%) |
| Mar 2025 | - | $472.20M(+8.7%) |
| Dec 2024 | $1.43B(+25.1%) | $434.60M(-1.2%) |
| Sep 2024 | - | $439.80M(+0.7%) |
| Jun 2024 | - | $436.80M(+17.7%) |
| Mar 2024 | - | $371.10M(-6.7%) |
| Dec 2023 | $1.14B(+19.4%) | $397.60M(+16.3%) |
| Sep 2023 | - | $341.80M(+1.3%) |
| Jun 2023 | - | $337.30M(+26.8%) |
| Mar 2023 | - | $266.00M(-26.0%) |
| Dec 2022 | $956.60M(-15.3%) | $359.40M(+29.9%) |
| Sep 2022 | - | $276.70M(-21.1%) |
| Jun 2022 | - | $350.90M(+58.1%) |
| Mar 2022 | - | $222.00M(-26.7%) |
| Dec 2021 | $1.13B(+27.0%) | $303.00M(+7.4%) |
| Sep 2021 | - | $282.00M(+3.0%) |
| Jun 2021 | - | $273.90M(-21.9%) |
| Mar 2021 | - | $350.80M(+22.6%) |
| Dec 2020 | $889.70M(-45.6%) | $286.10M(+37.0%) |
| Sep 2020 | - | $208.90M(-18.0%) |
| Jun 2020 | - | $254.90M(+16.6%) |
| Mar 2020 | - | $218.60M(-15.4%) |
| Dec 2019 | $1.64B(+99.0%) | $258.50M(-3.9%) |
| Sep 2019 | - | $269.10M(+59.7%) |
| Jun 2019 | - | $168.50M(-80.3%) |
| Mar 2019 | - | $857.20M(+171.2%) |
| Dec 2018 | $822.40M(+17.4%) | $316.10M(+3.2%) |
| Sep 2018 | - | $306.20M(+12.7%) |
| Jun 2018 | - | $271.60M(+87.7%) |
| Mar 2018 | - | $144.70M(-67.5%) |
| Dec 2017 | $700.40M(+30.4%) | $445.70M(+163.4%) |
| Sep 2017 | - | $169.20M(-66.2%) |
| Jun 2017 | - | $500.60M(+160.9%) |
| Mar 2017 | - | $191.90M(-35.8%) |
| Dec 2016 | $537.10M(-30.0%) | $298.70M(+21.2%) |
| Sep 2016 | - | $246.40M(+19.3%) |
| Jun 2016 | - | $206.50M(+54.7%) |
| Mar 2016 | - | $133.50M(-55.5%) |
| Dec 2015 | $766.80M(+2.3%) | $300.23M(+483.9%) |
| Sep 2015 | - | -$78.20M(-131.5%) |
| Jun 2015 | - | $247.95M(-28.0%) |
| Mar 2015 | - | $344.14M(+49.4%) |
| Dec 2014 | $749.70M(-9.1%) | $230.43M(-35.1%) |
| Sep 2014 | - | $355.19M(+68.4%) |
| Jun 2014 | - | $210.95M(+38.9%) |
| Mar 2014 | - | $151.88M(-52.4%) |
| Dec 2013 | $824.49M(+66.8%) | $319.33M(+33.3%) |
| Sep 2013 | - | $239.54M(+19.3%) |
| Jun 2013 | - | $200.74M(+9.8%) |
| Mar 2013 | - | $182.81M(+13.9%) |
| Dec 2012 | $494.43M | $160.56M(-2.3%) |
| Sep 2012 | - | $164.36M(+7.2%) |
| Jun 2012 | - | $153.26M(+14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $133.45M(-12.2%) |
| Dec 2011 | $425.40M(+0.9%) | $151.99M(+25.5%) |
| Sep 2011 | - | $121.13M(+10.3%) |
| Jun 2011 | - | $109.86M(-26.4%) |
| Mar 2011 | - | $149.23M(-4.9%) |
| Dec 2010 | $421.59M(+22.6%) | $156.93M(+19.6%) |
| Sep 2010 | - | $131.25M(+31.5%) |
| Jun 2010 | - | $99.78M(-9.2%) |
| Mar 2010 | - | $109.95M(-2.1%) |
| Dec 2009 | $343.85M(-5.4%) | $112.25M(+31.6%) |
| Sep 2009 | - | $85.28M(-1.2%) |
| Jun 2009 | - | $86.32M(+29.7%) |
| Mar 2009 | - | $66.53M(-57.6%) |
| Dec 2008 | $363.55M(+77.7%) | $157.01M(+151.6%) |
| Sep 2008 | - | $62.41M(+15.1%) |
| Jun 2008 | - | $54.23M(+7.1%) |
| Mar 2008 | - | $50.64M(-12.6%) |
| Dec 2007 | $204.64M(+56.6%) | $57.91M(+31.0%) |
| Sep 2007 | - | $44.20M(-4.0%) |
| Jun 2007 | - | $46.02M(+7.2%) |
| Mar 2007 | - | $42.95M(+543.6%) |
| Dec 2006 | $130.65M(+78.9%) | -$9.68M(-130.3%) |
| Sep 2006 | - | $31.92M(-2.0%) |
| Jun 2006 | - | $32.57M(+5.6%) |
| Mar 2006 | - | $30.86M(>+9900.0%) |
| Dec 2005 | $73.02M(+20.9%) | $231.00K(-98.7%) |
| Sep 2005 | - | $17.25M(-3.5%) |
| Jun 2005 | - | $17.88M(+15.0%) |
| Mar 2005 | - | $15.55M(+5.6%) |
| Dec 2004 | $60.38M(-6.9%) | $14.72M(+7.2%) |
| Sep 2004 | - | $13.73M(-3.0%) |
| Jun 2004 | - | $14.16M(-8.8%) |
| Mar 2004 | - | $15.53M(-7.6%) |
| Dec 2003 | $64.87M(+34.8%) | $16.81M(+2.7%) |
| Sep 2003 | - | $16.38M(+0.1%) |
| Jun 2003 | - | $16.36M(+18.9%) |
| Mar 2003 | - | $13.76M(-7.0%) |
| Dec 2002 | $48.12M(-8.6%) | $14.81M(-14.5%) |
| Sep 2002 | - | $17.32M(+17.4%) |
| Jun 2002 | - | $14.74M(+108.1%) |
| Mar 2002 | - | $7.08M(-21.7%) |
| Dec 2001 | $52.67M(-37.0%) | $9.05M(-18.7%) |
| Sep 2001 | - | $11.13M(-7.0%) |
| Jun 2001 | - | $11.96M(+9.9%) |
| Mar 2001 | - | $10.88M(-66.7%) |
| Dec 2000 | $83.55M(+133.4%) | $32.66M(+340.3%) |
| Sep 2000 | - | $7.42M(-74.7%) |
| Jun 2000 | - | $29.36M(+257.1%) |
| Mar 2000 | - | $8.22M(-9.6%) |
| Dec 1999 | $35.80M(+167.2%) | $9.10M(+41.8%) |
| Sep 1999 | - | $6.41M(+4.4%) |
| Jun 1999 | - | $6.14M(-50.0%) |
| Mar 1999 | - | $12.29M |
| Dec 1998 | $13.40M | - |
FAQ
- What is United Therapeutics Corporation annual total expenses?
- What is the all-time high annual total expenses for United Therapeutics Corporation?
- What is United Therapeutics Corporation annual total expenses year-on-year change?
- What is United Therapeutics Corporation quarterly total expenses?
- What is the all-time high quarterly total expenses for United Therapeutics Corporation?
- What is United Therapeutics Corporation quarterly total expenses year-on-year change?
What is United Therapeutics Corporation annual total expenses?
The current annual total expenses of UTHR is $1.43B
What is the all-time high annual total expenses for United Therapeutics Corporation?
United Therapeutics Corporation all-time high annual total expenses is $1.64B
What is United Therapeutics Corporation annual total expenses year-on-year change?
Over the past year, UTHR annual total expenses has changed by +$286.70M (+25.09%)
What is United Therapeutics Corporation quarterly total expenses?
The current quarterly total expenses of UTHR is $460.80M
What is the all-time high quarterly total expenses for United Therapeutics Corporation?
United Therapeutics Corporation all-time high quarterly total expenses is $857.20M
What is United Therapeutics Corporation quarterly total expenses year-on-year change?
Over the past year, UTHR quarterly total expenses has changed by +$21.00M (+4.77%)